HCA Healthcare HCA
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
HCA Healthcare (HCA) Business Model and Operations Summary
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2024, the firm owned and operated 190 hospitals, 124 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
Key Insights
HCA Healthcare (HCA) Core Market Data and Business Metrics
Latest Closing Price
$345.73Market Cap
$85.12 BillionPrice-Earnings Ratio
15.52Total Outstanding Shares
246.20 Million SharesTotal Employees
316,000Dividend
$0.72 Per Share QuarterlyIPO Date
March 10, 2011SIC Description
Services-general Medical & Surgical Hospitals, NecPrimary Exchange
New York Stock ExchangeHeadquarters
One Park Plz, Nashville, TN, 37203
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow | $2.00 Billion |
| Net Cash Flow From Operating Activities, Continuing | $10.63 Billion |
| Net Cash Flow From Financing Activities, Continuing | $-3.46 Billion |
| Net Cash Flow From Operating Activities | $10.63 Billion |
| Net Cash Flow From Investing Activities | $-5.18 Billion |
| Net Cash Flow From Financing Activities | $-3.46 Billion |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Costs And Expenses | $60.89 Billion |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Basic Average Shares | $259.00 Million |
| Interest Expense, Operating | $2.02 Billion |
| Net Income/Loss | $6.83 Billion |
| Net Income/Loss Attributable To Noncontrolling Interest | $903 Million |
Comprehensive Income
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $649 Million |
| Comprehensive Income/Loss | $6.95 Billion |
| Other Comprehensive Income/Loss | $1.97 Billion |
| Comprehensive Income/Loss Attributable To Parent | $6.30 Billion |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Equity Attributable To Noncontrolling Interest | $2.97 Billion |
| Other Current Assets | $14.89 Billion |
| Current Liabilities | $14.90 Billion |
| Equity | $786 Million |
| Inventory | $1.78 Billion |
| Accounts Payable | $4.24 Billion |
Historical Dividends
Current dividend: $0.72 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Jan 24, 2025 | Mar 31, 2025 | Mar 17, 2025 | $0.72 | Quarterly |
| Oct 25, 2024 | Dec 27, 2024 | Dec 13, 2024 | $0.66 | Quarterly |
| Jul 23, 2024 | Sep 30, 2024 | Sep 16, 2024 | $0.66 | Quarterly |
| Apr 26, 2024 | Jun 28, 2024 | Jun 14, 2024 | $0.66 | Quarterly |
| Jan 30, 2024 | Mar 29, 2024 | Mar 15, 2024 | $0.66 | Quarterly |
| Oct 24, 2023 | Dec 28, 2023 | Dec 14, 2023 | $0.6 | Quarterly |